Mork Capital Management’s Organon & Co OGN Stock Holding History

Mork Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,050	Closed	-$522K	–	144
2023 Q3	$522K	Hold	30,050	–	–	0.41%	112
2023 Q2	$625K	Hold	30,050	–	–	0.48%	108
2023 Q1	$707K	Hold	30,050	–	–	0.57%	102
2022 Q4	$839K	Buy	+30,050	New	+$768K	0.64%	90

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Mork Capital Management's OGN Position: Q4 2023 in Review

Mork Capital Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 30,050 shares — an estimated $522K sold.

Mork Capital Management first reported a position in OGN in Q4 2022 and held it in 4 quarters. The position peaked at $839K in Q4 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Mork Capital Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Mork Capital Management sold 30,050 Organon & Co shares in Q4 2023, an estimated $522K.
Mork Capital Management first reported a position in Organon & Co in Q4 2022 and held it in 4 quarters.
Mork Capital Management's Organon & Co position peaked at $839K in Q4 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Mork Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.